vs
LIFECORE BIOMEDICAL, INC. \DE\（LFCR）与RBB Bancorp（RBB）财务数据对比。点击上方公司名可切换其他公司
RBB Bancorp的季度营收约是LIFECORE BIOMEDICAL, INC. \DE\的1.0倍（$32.3M vs $31.1M），RBB Bancorp净利率更高（31.5% vs -32.1%，领先63.6%），RBB Bancorp同比增速更快（12.6% vs -4.5%），RBB Bancorp自由现金流更多（$42.6M vs $25.0K），过去两年RBB Bancorp的营收复合增速更高（7.0% vs -0.1%）
LIFECORE BIOMEDICAL, INC.是一家生物医药企业，专注于研发和生产以透明质酸为主的高品质生物材料，业务覆盖医疗应用产品、制药解决方案、个人护理原料三大核心板块，主要市场遍布北美、欧洲、亚太地区，服务头部医疗器械、制药、美妆品牌客户。
RBB银行控股公司是总部位于美国的金融控股集团，旗下核心主体为皇家商业银行，主要服务亚裔社群、中小微企业、不动产投资者及零售客户，提供商业信贷、储蓄存款、财富管理等多元金融服务，业务覆盖美国沿海核心都会区。
LFCR vs RBB — 直观对比
营收规模更大
RBB
是对方的1.0倍
$31.1M
营收增速更快
RBB
高出17.0%
-4.5%
净利率更高
RBB
高出63.6%
-32.1%
自由现金流更多
RBB
多$42.6M
$25.0K
两年增速更快
RBB
近两年复合增速
-0.1%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $31.1M | $32.3M |
| 净利润 | $-10.0M | $10.2M |
| 毛利率 | 25.0% | — |
| 营业利润率 | -9.9% | 39.5% |
| 净利率 | -32.1% | 31.5% |
| 营收同比 | -4.5% | 12.6% |
| 净利润同比 | -52.0% | 132.1% |
| 每股收益（稀释后） | $-0.29 | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LFCRRBB
| Q4 25 | — | $32.3M | ||
| Q3 25 | $31.1M | $32.6M | ||
| Q2 25 | — | $35.8M | ||
| Q1 25 | $35.2M | $28.5M | ||
| Q4 24 | $32.6M | $28.7M | ||
| Q3 24 | $24.7M | $30.3M | ||
| Q2 24 | — | $27.5M | ||
| Q1 24 | $35.7M | $28.2M |
净利润LFCRRBB
| Q4 25 | — | $10.2M | ||
| Q3 25 | $-10.0M | $10.1M | ||
| Q2 25 | — | $9.3M | ||
| Q1 25 | $-14.8M | $2.3M | ||
| Q4 24 | $-6.6M | $4.4M | ||
| Q3 24 | $-16.2M | $7.0M | ||
| Q2 24 | — | $7.2M | ||
| Q1 24 | $15.6M | $8.0M |
毛利率LFCRRBB
| Q4 25 | — | — | ||
| Q3 25 | 25.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 28.0% | — | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 33.3% | — |
营业利润率LFCRRBB
| Q4 25 | — | 39.5% | ||
| Q3 25 | -9.9% | 40.7% | ||
| Q2 25 | — | 36.1% | ||
| Q1 25 | -25.7% | 11.2% | ||
| Q4 24 | -6.0% | 17.6% | ||
| Q3 24 | -46.9% | 31.6% | ||
| Q2 24 | — | 35.6% | ||
| Q1 24 | -2.5% | 39.9% |
净利率LFCRRBB
| Q4 25 | — | 31.5% | ||
| Q3 25 | -32.1% | 31.2% | ||
| Q2 25 | — | 26.1% | ||
| Q1 25 | -42.0% | 8.0% | ||
| Q4 24 | -20.2% | 15.3% | ||
| Q3 24 | -65.7% | 23.1% | ||
| Q2 24 | — | 26.4% | ||
| Q1 24 | 43.8% | 28.4% |
每股收益（稀释后）LFCRRBB
| Q4 25 | — | $0.59 | ||
| Q3 25 | $-0.29 | $0.59 | ||
| Q2 25 | — | $0.52 | ||
| Q1 25 | $-0.47 | $0.13 | ||
| Q4 24 | $-0.25 | $0.26 | ||
| Q3 24 | $-0.53 | $0.39 | ||
| Q2 24 | — | $0.39 | ||
| Q1 24 | $0.42 | $0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $18.9M | $212.3M |
| 总债务越低越好 | $136.0M | $119.9M |
| 股东权益账面价值 | $-10.5M | $523.4M |
| 总资产 | $235.2M | $4.2B |
| 负债/权益比越低杠杆越低 | — | 0.23× |
8季度趋势，按日历期对齐
现金及短期投资LFCRRBB
| Q4 25 | — | $212.3M | ||
| Q3 25 | $18.9M | $234.9M | ||
| Q2 25 | — | $191.9M | ||
| Q1 25 | $5.4M | $238.8M | ||
| Q4 24 | $9.5M | $257.7M | ||
| Q3 24 | — | $349.4M | ||
| Q2 24 | — | $252.8M | ||
| Q1 24 | — | — |
总债务LFCRRBB
| Q4 25 | — | $119.9M | ||
| Q3 25 | $136.0M | $119.8M | ||
| Q2 25 | — | $119.7M | ||
| Q1 25 | $124.9M | $119.6M | ||
| Q4 24 | $111.3M | $119.5M | ||
| Q3 24 | $106.3M | $119.4M | ||
| Q2 24 | — | $119.3M | ||
| Q1 24 | $97.1M | $119.2M |
股东权益LFCRRBB
| Q4 25 | — | $523.4M | ||
| Q3 25 | $-10.5M | $514.3M | ||
| Q2 25 | — | $517.7M | ||
| Q1 25 | $2.2M | $510.3M | ||
| Q4 24 | $15.4M | $507.9M | ||
| Q3 24 | $-3.9M | $509.7M | ||
| Q2 24 | — | $511.3M | ||
| Q1 24 | $17.7M | $514.0M |
总资产LFCRRBB
| Q4 25 | — | $4.2B | ||
| Q3 25 | $235.2M | $4.2B | ||
| Q2 25 | — | $4.1B | ||
| Q1 25 | $237.7M | $4.0B | ||
| Q4 24 | $255.4M | $4.0B | ||
| Q3 24 | $246.8M | $4.0B | ||
| Q2 24 | — | $3.9B | ||
| Q1 24 | $246.2M | $3.9B |
负债/权益比LFCRRBB
| Q4 25 | — | 0.23× | ||
| Q3 25 | — | 0.23× | ||
| Q2 25 | — | 0.23× | ||
| Q1 25 | 56.05× | 0.23× | ||
| Q4 24 | 7.20× | 0.24× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | 5.49× | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.8M | $43.4M |
| 自由现金流经营现金流 - 资本支出 | $25.0K | $42.6M |
| 自由现金流率自由现金流/营收 | 0.1% | 131.8% |
| 资本支出强度资本支出/营收 | 5.6% | 2.5% |
| 现金转化率经营现金流/净利润 | — | 4.26× |
| 过去12个月自由现金流最近4个季度 | $-16.8M | $73.5M |
8季度趋势，按日历期对齐
经营现金流LFCRRBB
| Q4 25 | — | $43.4M | ||
| Q3 25 | $1.8M | $2.1M | ||
| Q2 25 | — | $21.7M | ||
| Q1 25 | $1.2M | $7.8M | ||
| Q4 24 | $-6.1M | $58.5M | ||
| Q3 24 | $-613.0K | $24.5M | ||
| Q2 24 | — | $11.7M | ||
| Q1 24 | $-1.4M | $4.8M |
自由现金流LFCRRBB
| Q4 25 | — | $42.6M | ||
| Q3 25 | $25.0K | $1.8M | ||
| Q2 25 | — | $21.6M | ||
| Q1 25 | $-4.3M | $7.6M | ||
| Q4 24 | $-8.6M | $57.7M | ||
| Q3 24 | $-4.0M | $24.2M | ||
| Q2 24 | — | $11.5M | ||
| Q1 24 | $-7.8M | $4.7M |
自由现金流率LFCRRBB
| Q4 25 | — | 131.8% | ||
| Q3 25 | 0.1% | 5.4% | ||
| Q2 25 | — | 60.2% | ||
| Q1 25 | -12.1% | 26.7% | ||
| Q4 24 | -26.3% | 201.0% | ||
| Q3 24 | -16.3% | 80.0% | ||
| Q2 24 | — | 42.0% | ||
| Q1 24 | -21.8% | 16.6% |
资本支出强度LFCRRBB
| Q4 25 | — | 2.5% | ||
| Q3 25 | 5.6% | 1.1% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | 15.5% | 0.6% | ||
| Q4 24 | 7.5% | 2.7% | ||
| Q3 24 | 13.9% | 0.8% | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | 17.8% | 0.5% |
现金转化率LFCRRBB
| Q4 25 | — | 4.26× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 2.32× | ||
| Q1 25 | — | 3.39× | ||
| Q4 24 | — | 13.34× | ||
| Q3 24 | — | 3.50× | ||
| Q2 24 | — | 1.61× | ||
| Q1 24 | -0.09× | 0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
RBB
暂无分部数据
